Seeking GLP-1 in desperation

Unsurprisingly, treating addiction often requires some wealth. A journalist’s experience buying GLP-1s on the gray market shows the risks one goes through when they cannot afford or access effective treatment. “Like me, they’ve turned to research-grade peptides labeled not for human consumption… Trump’s $150 plan can’t help people like me.”